Patient Square Capital

Patient Square Capital is a dedicated health care investment firm that aims to achieve strong investment returns by collaborating with high-quality, growth-oriented companies and top-tier management teams whose products, services, and technologies improve health. The firm utilizes deep industry expertise, a broad network of relationships, and a partnership approach to make investments in companies that strive to improve patient lives, strengthen communities, and create a healthier world.

Established in 2020, Patient Square Capital has rapidly grown its assets under management, reaching approximately $13 billion as of March 31, 2025. The firm focuses on a patient-centric investment strategy, emphasizing long-term partnerships with management teams to drive sustainable growth and innovation in the healthcare sector.

Patient Square Capital's portfolio includes a diverse range of companies across various healthcare subsectors, such as biopharmaceuticals, medical devices, diagnostics, digital health, and consumer health. The firm's investment approach is characterized by a relentless focus on patient outcomes, leveraging its extensive industry knowledge and resources to support the development and expansion of its portfolio companies.